Back to Search
JESSE MISER, MD
MD
Anesthesiology Physician
NPI: 1255997177IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
R-11477(IA)01090363A(IN)
CMS Specialties
PrimaryANESTHESIOLOGY
Education
INDIANA UNIVERSITY SCHOOL OF MEDICINE
Class of 2019
Research & Publications (16)
Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study.
PMID 19349548·J Clin Oncol·2009
4-observational
Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group.
PMID 17539021·Pediatr Blood Cancer·2008
3-trial
Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Children's Oncology Group.
PMID 18506764·Pediatr Blood Cancer·2008
8-other
High-dose therapy with hematopoietic stem cell rescue in patients with poor prognosis Ewing family tumors.
PMID 18587438·Bone Marrow Transplant·2008
3-trial
Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group.
PMID 16547940·Pediatr Blood Cancer·2007
4-observational
Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group.
PMID 17584910·Pediatr Blood Cancer·2007
3-trial
Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group.
PMID 16985182·Blood·2007
4-observational
Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group.
PMID 16921035·J Clin Oncol·2006
2-rct
Very high-dose methotrexate (33.6 g/m(2)) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: results of National Cancer Institute/Children's Cancer Group trials CCG-191P, CCG-134P and CCG-144P.
PMID 17169794·Leuk Lymphoma·2006
2-rct
Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
PMID 15254055·J Clin Oncol·2004
3-trial
Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy.
PMID 14530727·Ann Surg·2003
3-trial
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
PMID 12594313·N Engl J Med·2003
3-trial
Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent or refractory solid tumors: a children's cancer group report.
PMID 11196267·J Pediatr Hematol Oncol·2001
3-trial
Ewing sarcoma of the rib: results of an intergroup study with analysis of outcome by timing of resection.
PMID 10838532·J Thorac Cardiovasc Surg·2000
3-trial
Granulocyte colony stimulating factor permits dose intensification by interval compression in the treatment of Ewing's sarcomas and soft tissue sarcomas in children.
PMID 10741300·Eur J Cancer·2000
8-other
Very intensive, short-term chemotherapy for children and adolescents with metastatic sarcomas.
PMID 10611582·Med Pediatr Oncol·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 801 N STATE ST
GREENFIELD, IN 46140 - Phone
- (317) 462-5544
Quick Facts
- NPI
- 1255997177
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 7
- Publications
- 16
Are you this provider?
Claim Your Profile